prikaz prve stranice dokumenta International validation of the questionnaire for assessment of health‐related quality of life for patients with chronic lymphocytic leukaemia
No public access
Scientific paper - Original scientific paper
International validation of the questionnaire for assessment of health‐related quality of life for patients with chronic lymphocytic leukaemia
British Journal of Haematology, (2022); https://doi.org/10.1111/bjh.18072
(EORTC Quality of Life Group) Oerlemans, Simone; Efficace, Fabio; Kieffer, Jacobien M.; Kyriakou, Charalampia; Xochelli, Aliki; Levedahl, Kerstin; Petranović, Duška; Borges, Fabio Cardoso; Bredart, Anne; Shamieh, Omar; Gziskevicius, Laimonas; Lehmann, Jens; Scholz, Christian W.; Caocci, Giovanni; Molica, Stefano; Stamatopoulos, Kostas; Panteliadou, Alkistis‐Kyra; Papaioannou, Maria; Alrjoob, Waleed; Baliakas, Panagiotis; Rosenquist, Richard; Malak, Sandra; Miranda, Ana; Cocks, Kim; Poll‐Franse, Lonneke More authors...

Institutional repository: Repository of the University of Rijeka, Faculty of Medicine

Cite this document

Oerlemans, S., Efficace, F., Kieffer, J. M., Kyriakou, C., Xochelli, A., Levedahl, K. ... Poll‐Franse, L. (2022). International validation of the questionnaire for assessment of health‐related quality of life for patients with chronic lymphocytic leukaemia. British Journal of Haematology. doi: 10.1111/bjh.18072

Oerlemans, Simone, et al. "International validation of the questionnaire for assessment of health‐related quality of life for patients with chronic lymphocytic leukaemia." British Journal of Haematology, 2022. https://doi.org/10.1111/bjh.18072

Oerlemans, Simone, Fabio Efficace, Jacobien M. Kieffer, Charalampia Kyriakou, Aliki Xochelli, Kerstin Levedahl, Duška Petranović, et al. "International validation of the questionnaire for assessment of health‐related quality of life for patients with chronic lymphocytic leukaemia." British Journal of Haematology (2022). https://doi.org/10.1111/bjh.18072

Oerlemans, S., et al. (2022) 'International validation of the questionnaire for assessment of health‐related quality of life for patients with chronic lymphocytic leukaemia', British Journal of Haematology. doi: 10.1111/bjh.18072

Oerlemans S, Efficace F, Kieffer JM, Kyriakou C, Xochelli A, Levedahl K, and sur.. International validation of the questionnaire for assessment of health‐related quality of life for patients with chronic lymphocytic leukaemia. British Journal of Haematology [Internet]. 2022 March 07 [cited 2024 November 23]. doi: 10.1111/bjh.18072

S. Oerlemans, et al., "International validation of the questionnaire for assessment of health‐related quality of life for patients with chronic lymphocytic leukaemia", British Journal of Haematology, March 2022. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:184:932551. [Accessed: 23 November 2024]

Metadata
Title (english)International validation of the questionnaire for assessment of health‐related quality of life for patients with chronic lymphocytic leukaemia
AuthorSimone Oerlemans
AuthorFabio Efficace
AuthorJacobien M. Kieffer
AuthorCharalampia Kyriakou
AuthorAliki Xochelli
AuthorKerstin Levedahl
AuthorDuška Petranović
AuthorFabio Cardoso Borges
AuthorAnne Bredart
AuthorOmar Shamieh
AuthorLaimonas Gziskevicius
AuthorJens Lehmann
AuthorChristian W. Scholz
AuthorGiovanni Caocci
AuthorStefano Molica
AuthorKostas Stamatopoulos
AuthorAlkistis‐Kyra Panteliadou
AuthorMaria Papaioannou
AuthorWaleed Alrjoob
AuthorPanagiotis Baliakas
AuthorRichard Rosenquist
AuthorSandra Malak
AuthorAna Miranda
AuthorKim Cocks
AuthorLonneke Poll‐Franse
CollaborationEORTC Quality of Life Group
Author's institutionUniversity of Rijeka
Faculty of Medicine
(Department of Internal Medicine)
Scientific / art field,
discipline and subdiscipline		BIOMEDICINE AND HEALTHCARE
Clinical Medical Sciences
Internal Medicine
Abstract (english)
Selecting the most appropriate chronic lymphocytic leukaemia (CLL) treatment is challenging. Patient-reported health-related quality of life (HRQoL) is therefore a critical aspect to consider. This international study by the European Organization for Research and Treatment of Cancer (EORTC) tested the psychometric properties of a newly developed measure for CLL patients: the EORTC QLQ-CLL17 to supplement the core questionnaire (EORTC QLQ-C30). Patients with CLL (n = 341) from 12 countries completed the QLQ-C30, QLQ-CLL17 and a debriefing questionnaire. Sociodemographic and clinical data were recorded from medical records. A high percentage (30%-66%) reported symptoms and/or worries (e.g. aches/pains in muscles, lack of energy and worry/fears about health). Confirmatory factor analysis showed an acceptable to good fit of the 17 items on the three scales (i.e. symptom burden, physical condition/fatigue and worries/fears about health and functioning). Completion took on average 8 min. Test-retest and convergent validity was demonstrated. The QLQ-CLL17 differentiated between patients with an Eastern Cooperative Oncology group (ECOG) performance of 0 versus 1-3 (p's < 0.01 and clinically relevant). The newly developed EORTC QLQ-CLL17 will increase sensitivity of HRQoL assessment in patients with CLL. Implementation of this questionnaire both in clinical research and practice will help to generate unique clinically relevant data to better inform CLL treatment decision-making.
Keywords (english)
Languageenglish
Publication typeScientific paper - Original scientific paper
Publication statusAccepted
Peer reviewPeer review - international
Publication versionPublished version
Journal titleBritish Journal of Haematology
p-ISSN0007-1048
e-ISSN1365-2141
DOIhttps://doi.org/10.1111/bjh.18072
URN:NBNurn:nbn:hr:184:932551
Publication2022-03-07
Document URLhttps://onlinelibrary.wiley.com/doi/10.1111/bjh.18072
Type of resourceText
Access conditionsClosed access
Terms of useLicence In copyright icon
Created on2022-03-10 21:41:01